| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $910.5M | +104.7% |
| R&D Expense | $56.1M | +25.2% |
| SG&A Expense | $116.7M | -6.7% |
| Operating Income | $114.1M | +122.5% |
| Interest Expense | $68.2M | +77.5% |
| Pre-tax Income | $26.8M | +47.9% |
| Income Tax | $13.9M | +216.5% |
| Net Income | $12.9M | -6.0% |
| EPS (Basic) | $0.10 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.2M | +199.8% |
| Accounts Receivable | $112.6M | +0.9% |
| Inventory | $98.9M | +0.9% |
| Current Assets | $431.9M | +33.7% |
| Total Assets | $1.30B | +6.1% |
| Current Liabilities | $269.2M | +47.9% |
| Long-term Debt | $833.6M | +0.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $124.5M | +200.5% |
| Capital Expenditures | $59.4M | +339.7% |
| Investing Cash Flow | -$39.9M | +88.2% |
| Financing Cash Flow | -$1.4M | -100.7% |
| Free Cash Flow | $65.1M | +133.2% |
| -9.1% |
| EPS (Diluted) | $0.09 | -10.0% |
| Total Liabilities |
| $1.20B |
| +3.7% |
| Stockholders' Equity | $101.1M | +45.9% |